Incannex Healthcare Inc. 8-K Filing
Ticker: IXHL · Form: 8-K · Filed: Dec 3, 2025 · CIK: 1873875
| Field | Detail |
|---|---|
| Company | Incannex Healthcare Inc. (IXHL) |
| Form Type | 8-K |
| Filed Date | Dec 3, 2025 |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Incannex Healthcare Inc. (ticker: IXHL) to the SEC on Dec 3, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (nge on which registered Common Stock, $0.0001 par value per share IXHL The Nasdaq).
How long is this filing?
Incannex Healthcare Inc.'s 8-K filing is 1 pages with approximately 446 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 446 words · 2 min read · ~1 pages · Grade level 10.8 · Accepted 2025-12-03 08:00:30
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IXHL The Nasdaq
Filing Documents
- ea0268145-8k_incannex.htm (8-K) — 25KB
- ea026814501ex99-1_incannex.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001213900-25-117571.txt ( ) — 215KB
- ixhl-20251203.xsd (EX-101.SCH) — 3KB
- ixhl-20251203_lab.xml (EX-101.LAB) — 33KB
- ixhl-20251203_pre.xml (EX-101.PRE) — 22KB
- ea0268145-8k_incannex_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On December 3, 2025, Incannex Healthcare Inc. (the "Company") issued a press release announcing that the Company was granted U.S. Food and Drug Administration Fast Track designation for IHL-42X in obstructive sleep apnea. A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Incannex Healthcare Inc., dated December 3, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Incannex Healthcare Inc. Date: December 3, 2025 /s/ Joel Latham Name: Joel Latham Title: Chief Executive Officer and President 2